VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!

Dr. Laura Dawson on HCC Challenges

Laura Dawson, MD
Published: Monday, Jan 19, 2015



Laura Dawson, MD, Princess Margaret Hospital, University of Toronto, talks about the challenges in treating hepatocellular carcinoma (HCC).

Large portions of patients with HCC present with locally advanced disease and don’t get any chance for treatment because disease is too far progressed. This is mainly due to a lack of screening for the disease, says Dawson.

Research focus should be on detection methods for early stage HCC. Those at high risk, including those with hepatitis B or C or cirrhosis, should be screened regularly for the disease.



Laura Dawson, MD, Princess Margaret Hospital, University of Toronto, talks about the challenges in treating hepatocellular carcinoma (HCC).

Large portions of patients with HCC present with locally advanced disease and don’t get any chance for treatment because disease is too far progressed. This is mainly due to a lack of screening for the disease, says Dawson.

Research focus should be on detection methods for early stage HCC. Those at high risk, including those with hepatitis B or C or cirrhosis, should be screened regularly for the disease.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
34th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series™May 25, 20182.0
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Publication Bottom Border
Border Publication
x